Advertisement

The Scientist

» drug development, ecology, microbiology and culture

Most Recent

image: Book Excerpt from <em>Life on the Edge</em>

Book Excerpt from Life on the Edge

By | August 1, 2015

In Chapter 4, “The quantum beat,” authors Johnjoe McFadden and Jim Al-Khalili rethink Newton’s apple from a quantum-biological perspective.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | August 1, 2015

Gods of the Morning, Hedonic Eating, A Beautiful Question, and Genomic Messages

0 Comments

image: Good Vibrations

Good Vibrations

By | August 1, 2015

Does a delicately orchestrated balance between quantum and classical physics distinguish living from nonliving things?

0 Comments

image: Mimicry Muses

Mimicry Muses

By | August 1, 2015

The animal world is full of clever solutions to bioengineering challenges.

0 Comments

image: TB Traces

TB Traces

By | August 1, 2015

Take a trip to the mummy museum in Vác, Hungary, to see the human remains that helped researchers learn more about the origins of tuberculosis in Europe.

0 Comments

image: Anthrax Sent in Error to 86 Labs

Anthrax Sent in Error to 86 Labs

By | July 29, 2015

A US Army lab shipped live spores of the deadly bacterium because of improper irradiation protocols, a Department of Defense review has found.

1 Comment

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: EMA Green Lights Malaria Vax

EMA Green Lights Malaria Vax

By | July 27, 2015

The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.

0 Comments

image: Antibiotic Resistance Can Boost Bacterial Fitness

Antibiotic Resistance Can Boost Bacterial Fitness

By | July 22, 2015

In some pathogenic bacteria, certain antibiotic resistance–associated mutations may also confer an unexpected growth advantage.

0 Comments

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Advertisement